| Financial Year |
March 31 2023 |
| Monetary Funds |
881,403,866.63 |
| Held-for-trading Financial Assets |
11,000,000.00 |
| Notes Receivable |
-- |
| Accounts Receivable |
1,031,722,510.28 |
| Advances to Suppliers |
361,332,725.87 |
| Other Receivables |
50,022,041.39 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
1,528,724,163.23 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
30,000,000.00 |
| Other Current Assets |
242,356,276.17 |
| Total Current Assets |
4,355,845,868.08 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
251,626,879.81 |
| Investment Properties |
24,249,445.20 |
| Fixed Assetes |
3,160,899,987.85 |
| Under-construction Projects |
2,220,311,089.58 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
447,267,062.08 |
| R&D expenses |
119,785,084.50 |
| Goodwill |
600,936,834.86 |
| Long-Term Deferred and Prepaid Expenses |
10,232,163.30 |
| Deferred Income Tax Assets |
109,115,618.62 |
| Other Non-Current Assets |
213,810,749.67 |
| Sub-Total of Non-Current Assets |
7,227,516,951.91 |
| Total Assets |
11,583,362,819.99 |
| Short-Term Loans |
2,056,820,687.38 |
| Trading Financial liabilities |
3,348,165.64 |
| Notes Payable |
853,721,429.95 |
| Accounts Payable |
951,890,900.43 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
36,560,937.85 |
| Taxes Payable |
30,176,921.65 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
42,585,980.57 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
374,572,004.26 |
| Other Current Liabilities |
109,257,477.30 |
| Sub-Total of Current Liabilities |
5,452,877,144.19 |
| Long-term Loans |
1,451,429,225.09 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
770,808,337.34 |
| Special Payable |
-- |
| Estimatied Liabilities |
144,145.00 |
| Deferred Income Tax Liabilities |
16,126,691.87 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
2,366,343,789.64 |
| Total Liabilities |
7,819,220,933.83 |
| Paid-In Capital(Or Share Stock) |
876,566,295.00 |
| Capital Surplus |
208,995,086.37 |
| Surplus Reserve |
212,549,555.18 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
2,082,550,605.12 |
| Minority Stockholder's Interest |
310,247,485.27 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
3,453,894,400.89 |
| Owner's Equity（Stockholder's Equity） |
3,764,141,886.16 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
11,583,362,819.99 |
